CORD-19:02d18b4f484a0420c21595a95b8765125d4a484c / 12211-12682 JSONTXT

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T72","span":{"begin":0,"end":471},"obj":"Sentence"}],"text":"A broad range of ACE inhibitors, such as captopril and lisinopril does not affect the activity of ACE2 (Donoghue et al., 2000; Tipnis et al., 2000) , whereas ACE2 activity is inhibited by the dipeptide Pro-Phe (Guy et al., 2003) , and specific ACE2 inhibitors, such as the peptide analogues DX600 (Huang et al., 2003) and MLN 4760 ((S,S)-2-[1-carboxy-2-[3-(3,5-dichlorobenzyl)-3H-imidazol4-yl]-ethylamino]-4-methylpentanoicacid) have been developed (Dales et al., 2002) ."}

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T72","span":{"begin":0,"end":471},"obj":"Sentence"},{"id":"TextSentencer_T72","span":{"begin":0,"end":471},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"A broad range of ACE inhibitors, such as captopril and lisinopril does not affect the activity of ACE2 (Donoghue et al., 2000; Tipnis et al., 2000) , whereas ACE2 activity is inhibited by the dipeptide Pro-Phe (Guy et al., 2003) , and specific ACE2 inhibitors, such as the peptide analogues DX600 (Huang et al., 2003) and MLN 4760 ((S,S)-2-[1-carboxy-2-[3-(3,5-dichlorobenzyl)-3H-imidazol4-yl]-ethylamino]-4-methylpentanoicacid) have been developed (Dales et al., 2002) ."}